Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T11754
(Former ID: TTDS00177)
|
|||||
Target Name |
Fatty acid amide hydrolase (FAAH)
|
|||||
Synonyms |
Oleamidehydrolase; Anandamide amidohydrolase
Click to Show/Hide
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Successful target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Corneal disease [ICD-11: 9A76-9A78] | |||||
Function |
Degradesbioactive fatty acid amides like oleamide, the endogenous cannabinoid, anandamide and myristic amide to their corresponding acids, thereby serving to terminate the signaling functions of these molecules. Hydrolyzes polyunsaturated substrate anandamide preferentially as compared to monounsaturated substrates.
Click to Show/Hide
|
|||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Approved Drug(s) | [+] 2 Approved Drugs | + | ||||
1 | Propofol | Drug Info | Approved | Anaesthesia | [2], [3] | |
2 | Thiopental | Drug Info | Approved | Anaesthesia | [4], [5] | |
Clinical Trial Drug(s) | [+] 5 Clinical Trial Drugs | + | ||||
1 | IW-6118 | Drug Info | Phase 2 | Inflammation | [6] | |
2 | JNJ-42165279 | Drug Info | Phase 2 | Anxiety disorder | [7] | |
3 | PF-04457845 | Drug Info | Phase 2 | Liver disease | [8] | |
4 | SSR411298 | Drug Info | Phase 2 | Major depressive disorder | [9] | |
5 | IPI-940 | Drug Info | Phase 1 | Pain | [10] | |
Mode of Action | [+] 2 Modes of Action | + | ||||
Inhibitor | [+] 298 Inhibitor drugs | + | ||||
1 | Propofol | Drug Info | [1], [11] | |||
2 | Thiopental | Drug Info | [1] | |||
3 | JNJ-42165279 | Drug Info | [13] | |||
4 | PF-04457845 | Drug Info | [14] | |||
5 | SSR411298 | Drug Info | [15] | |||
6 | IPI-940 | Drug Info | [16] | |||
7 | Aryl urea derivative 1 | Drug Info | [17] | |||
8 | Aryl urea derivative 2 | Drug Info | [17] | |||
9 | Aryl urea derivative 3 | Drug Info | [17] | |||
10 | Aryl urea derivative 4 | Drug Info | [17] | |||
11 | Aryl urea derivative 5 | Drug Info | [17] | |||
12 | Azetidine urea derivative 1 | Drug Info | [17] | |||
13 | Azetidine urea derivative 2 | Drug Info | [17] | |||
14 | Azetidine urea derivative 3 | Drug Info | [17] | |||
15 | Azole derivative 1 | Drug Info | [17] | |||
16 | Azole derivative 2 | Drug Info | [17] | |||
17 | Azole derivative 3 | Drug Info | [17] | |||
18 | Azole derivative 4 | Drug Info | [17] | |||
19 | Azole derivative 5 | Drug Info | [17] | |||
20 | Benzoxazole derivative 1 | Drug Info | [17] | |||
21 | Benzyl pyrrolyloxoacetamide derivative 1 | Drug Info | [17] | |||
22 | Benzyl pyrrolyloxoacetamide derivative 2 | Drug Info | [17] | |||
23 | Boronic acid derivative 1 | Drug Info | [17] | |||
24 | Boronic acid derivative 2 | Drug Info | [17] | |||
25 | Boronic acid derivative 3 | Drug Info | [17] | |||
26 | Boronic acid derivative 4 | Drug Info | [17] | |||
27 | Boronic acid derivative 5 | Drug Info | [17] | |||
28 | Boronic acid derivative 6 | Drug Info | [17] | |||
29 | Carbamate derivative 1 | Drug Info | [17] | |||
30 | Carbamate derivative 10 | Drug Info | [18] | |||
31 | Carbamate derivative 16 | Drug Info | [18] | |||
32 | Carbamate derivative 17 | Drug Info | [18] | |||
33 | Carbamate derivative 3 | Drug Info | [17] | |||
34 | Carbamate derivative 7 | Drug Info | [17] | |||
35 | Carbamate derivative 8 | Drug Info | [17] | |||
36 | Carbamate derivative 9 | Drug Info | [18] | |||
37 | Carbamide derivative 1 | Drug Info | [17] | |||
38 | Carbamide derivative 24 | Drug Info | [18] | |||
39 | Carbamide derivative 25 | Drug Info | [18] | |||
40 | Carbamide derivative 26 | Drug Info | [18] | |||
41 | Enol carbamate derivative 1 | Drug Info | [17] | |||
42 | Ethylaminopyrimidine derivative 1 | Drug Info | [17] | |||
43 | Heteroaryl-substituted urea derivative 1 | Drug Info | [17] | |||
44 | Heteroaryl-substituted urea derivative 2 | Drug Info | [17] | |||
45 | Imidazolyl urea derivative 1 | Drug Info | [17] | |||
46 | Isoxazoline derivative 1 | Drug Info | [17] | |||
47 | Isoxazoline derivative 2 | Drug Info | [17] | |||
48 | Isoxazoline derivative 3 | Drug Info | [17] | |||
49 | Isoxazoline derivative 4 | Drug Info | [17] | |||
50 | Ketoheterocycle derivative 1 | Drug Info | [17] | |||
51 | Ketoheterocycle derivative 2 | Drug Info | [17] | |||
52 | Ketoheterocycle derivative 3 | Drug Info | [17] | |||
53 | Ketoheterocycle derivative 4 | Drug Info | [17] | |||
54 | N-alkyl-4-oxazolecar boxamide derivative 1 | Drug Info | [17] | |||
55 | N-alkyl-4-oxazolecar boxamide derivative 2 | Drug Info | [17] | |||
56 | Piperazine carbamic compound 1 | Drug Info | [18] | |||
57 | Piperazine carbamic compound 2 | Drug Info | [18] | |||
58 | Piperazine urea derivative 1 | Drug Info | [17] | |||
59 | PMID26413912-Compound-84 | Drug Info | [17] | |||
60 | PMID29053063-Compound-11d | Drug Info | [18] | |||
61 | PMID29053063-Compound-14 | Drug Info | [18] | |||
62 | PMID29053063-Compound-15 | Drug Info | [18] | |||
63 | Pyrazole derivative 80 | Drug Info | [18] | |||
64 | Pyrazole derivative 81 | Drug Info | [18] | |||
65 | Pyrazole derivative 82 | Drug Info | [18] | |||
66 | Pyrazole derivative 83 | Drug Info | [18] | |||
67 | Pyrazole derivative 84 | Drug Info | [18] | |||
68 | Pyrimidinyl ethylenediamine derivative 1 | Drug Info | [17] | |||
69 | Pyrrolidinyl urea derivative 1 | Drug Info | [17] | |||
70 | Spirocyclic diamine urea derivative 1 | Drug Info | [17] | |||
71 | Spirocyclic diamine urea derivative 2 | Drug Info | [17] | |||
72 | Tetra-hydro-naphthalene derivative 1 | Drug Info | [17] | |||
73 | Tetra-hydro-naphthalene derivative 2 | Drug Info | [17] | |||
74 | Tetra-hydro-naphthalene derivative 3 | Drug Info | [17] | |||
75 | Tetra-hydro-naphthyridine derivative 1 | Drug Info | [17] | |||
76 | Tetra-substituted urea derivative 1 | Drug Info | [17] | |||
77 | Tetra-substituted urea derivative 2 | Drug Info | [17] | |||
78 | Tetrazolyl urea derivative 1 | Drug Info | [17] | |||
79 | (+/-)-3-(but-3-enyl)-1-pent-4-enoylazetidin-2-one | Drug Info | [19] | |||
80 | (+/-)-3-(pent-4-enyl)azetidin-2-one | Drug Info | [19] | |||
81 | (+/-)-3-allyl-1-pent-4-enoylazetidin-2-one | Drug Info | [19] | |||
82 | (+/-)-3-allylazetidin-2-one | Drug Info | [19] | |||
83 | (+/-)-oxiran-2-ylmethyl (9Z)-hexadec-9-enoate | Drug Info | [20] | |||
84 | (+/-)-oxiran-2-ylmethyl (9Z)-octadec-9-enoate | Drug Info | [20] | |||
85 | (Z)-1,1,1-Trifluoro-nonadec-10-en-2-one | Drug Info | [21] | |||
86 | (Z)-1-(4-phenyloxazol-2-yl)octadec-9-en-1-one | Drug Info | [22] | |||
87 | (Z)-1-(benzo[d]oxazol-2-yl)octadec-9-en-1-one | Drug Info | [22] | |||
88 | (Z)-1-(pyridazin-3-yl)octadec-9-en-1-one | Drug Info | [22] | |||
89 | (Z)-2,2-Dimethyl-1-oxazol-2-yl-octadec-9-en-1-one | Drug Info | [23] | |||
90 | (Z)-2-Methyl-1-oxazol-2-yl-octadec-9-en-1-one | Drug Info | [23] | |||
91 | 1,1,1-trifluoro-3-(hexylthio)propan-2-one | Drug Info | [24] | |||
92 | 1,1,1-trifluoro-3-(octylsulfinyl)propan-2-one | Drug Info | [24] | |||
93 | 1,1,1-trifluoro-3-(octylsulfonyl)propan-2-one | Drug Info | [24] | |||
94 | 1,1,1-trifluoro-3-(octylthio)propan-2-one | Drug Info | [24] | |||
95 | 1,1,1-Trifluoro-7-phenylheptan-2-one | Drug Info | [21] | |||
96 | 1,1,1-Trifluoro-8-phenyl-octan-2-one | Drug Info | [21] | |||
97 | 1,1,1-Trifluoro-9-phenyl-nonan-2-one | Drug Info | [21] | |||
98 | 1,1,1-Trifluoro-nonadecan-2-one | Drug Info | [21] | |||
99 | 1,1,1-Trifluoro-tridecan-2-one | Drug Info | [21] | |||
100 | 1,1,1-Trifluoro-undecan-2-one | Drug Info | [21] | |||
101 | 1,1,1-trifluorododecan-2-one | Drug Info | [24] | |||
102 | 1,10-(methylenedi-4,1-phenylene)bismaleimide | Drug Info | [25] | |||
103 | 1,4-bis(malimido)xylene | Drug Info | [25] | |||
104 | 1,8-bis-maleimidodiethyleneglycol | Drug Info | [25] | |||
105 | 1-(1,2,4-Oxadiazol-3-yl)-7-phenylheptan-1-one | Drug Info | [26] | |||
106 | 1-(1,2,4-Oxadiazol-5-yl)-7-phenylheptan-1-one | Drug Info | [26] | |||
107 | 1-(1,3,4-Oxadiazol-2-yl)-7-phenylheptan-1-one | Drug Info | [26] | |||
108 | 1-(1,3,4-oxadiazol-2-yl)octadec-9-en-1-one | Drug Info | [26] | |||
109 | 1-(1,3,4-thiadiazol-2-yl)octadec-9-en-1-one | Drug Info | [26] | |||
110 | 1-(4-acetyloxazol-2-yl)-7-phenylheptan-1-one | Drug Info | [27] | |||
111 | 1-(4-bromooxazol-2-yl)-7-phenylheptan-1-one | Drug Info | [27] | |||
112 | 1-(4-chlorooxazol-2-yl)-7-phenylheptan-1-one | Drug Info | [27] | |||
113 | 1-(4-iodooxazol-2-yl)-7-phenylheptan-1-one | Drug Info | [27] | |||
114 | 1-(4-methoxyoxazol-2-yl)-7-phenylheptan-1-one | Drug Info | [27] | |||
115 | 1-(4-methyloxazol-2-yl)-7-phenylheptan-1-one | Drug Info | [27] | |||
116 | 1-(5-(furan-2-yl)oxazol-2-yl)octadec-9-en-1-one | Drug Info | [26] | |||
117 | 1-(5-(pyridin-2-yl)oxazol-2-yl)dodecan-1-one | Drug Info | [22] | |||
118 | 1-(5-(pyridin-2-yl)oxazol-2-yl)octadec-9-en-1-one | Drug Info | [26] | |||
119 | 1-(5-(pyridin-2-yl)oxazol-2-yl)octan-1-one | Drug Info | [22] | |||
120 | 1-(5-(pyridin-2-yl)oxazol-2-yl)pentan-1-one | Drug Info | [22] | |||
121 | 1-(5-fluorooxazol-2-yl)-7-phenylheptan-1-one | Drug Info | [22] | |||
122 | 1-(5-methyloxazol-2-yl)-7-phenylheptan-1-one | Drug Info | [22] | |||
123 | 1-(5-phenyloxazol-2-yl)octadec-9-en-1-one | Drug Info | [26] | |||
124 | 1-(5-Pyridin-2-yl-oxazol-2-yl)-octadec-9-yn-1-one | Drug Info | [21] | |||
125 | 1-(oxazol-2-yl)-3-(4-phenoxyphenyl)propan-1-one | Drug Info | [28] | |||
126 | 1-(oxazol-2-yl)-4-(piperidin-4-yl)butan-1-one | Drug Info | [29] | |||
127 | 1-(oxazol-2-yl)-7-phenylheptan-1-one | Drug Info | [27] | |||
128 | 1-(oxazol-2-yl)octadec-9-en-1-one | Drug Info | [26] | |||
129 | 1-(oxazolo[4,5-b]pyridin-2-yl)dodecan-1-one | Drug Info | [22] | |||
130 | 1-(oxazolo[4,5-b]pyridin-2-yl)octan-1-one | Drug Info | [22] | |||
131 | 1-(oxazolo[4,5-b]pyridin-2-yl)pentan-1-one | Drug Info | [22] | |||
132 | 1-Benzooxazol-2-yl-6-phenyl-hexan-1-one | Drug Info | [21] | |||
133 | 1-Biphenyl-4-ylmaleimide | Drug Info | [25] | |||
134 | 1-Biphenyl-4-ylmethylmaleimide | Drug Info | [25] | |||
135 | 1-DODECANOL | Drug Info | [30] | |||
136 | 1-Imidazol-1-yl-3-(4-octylphenoxy)propan-2-one | Drug Info | [31] | |||
137 | 1-Oxazolo[4,5-b]pyridin-2-yl-6-phenyl-hexan-1-one | Drug Info | [32] | |||
138 | 1-Oxazolo[4,5-b]pyridin-2-yl-octadec-9-yn-1-one | Drug Info | [21] | |||
139 | 2,2-dimethyl-3-methyleneheptadecane | Drug Info | [24] | |||
140 | 2,4-difluorophenyl 4-butoxybenzylcarbamate | Drug Info | [33] | |||
141 | 2-(7-phenylheptanoyl)oxazole-4-carbaldehyde | Drug Info | [27] | |||
142 | 2-(7-phenylheptanoyl)oxazole-4-carbonitrile | Drug Info | [27] | |||
143 | 2-(7-phenylheptanoyl)oxazole-4-carboxamide | Drug Info | [27] | |||
144 | 2-(7-phenylheptanoyl)oxazole-4-carboxylic acid | Drug Info | [27] | |||
145 | 2-(7-phenylheptanoyl)oxazole-5-carbonitrile | Drug Info | [27] | |||
146 | 2-(7-phenylheptanoyl)oxazole-5-carboxylic acid | Drug Info | [27] | |||
147 | 2-(biphenyl-4-yl)vinylboronic acid | Drug Info | [34] | |||
148 | 2-arachidonoylglycerol | Drug Info | [35] | |||
149 | 2-chloro-1-(5-(pyridin-2-yl)oxazol-2-yl)ethanone | Drug Info | [36] | |||
150 | 2-Cyclohexylacetic acidbiphenyl-3-yl ester | Drug Info | [37] | |||
151 | 2-fluorophenyl 1-(4-butoxyphenyl)propylcarbamate | Drug Info | [33] | |||
152 | 2-fluorophenyl 4'-ethylbiphenyl-4-ylcarbamate | Drug Info | [33] | |||
153 | 2-fluorophenyl 4-(decyloxy)phenylcarbamate | Drug Info | [33] | |||
154 | 2-fluorophenyl 4-(dodecyloxy)phenylcarbamate | Drug Info | [33] | |||
155 | 2-fluorophenyl 4-(heptyloxy)phenylcarbamate | Drug Info | [33] | |||
156 | 2-fluorophenyl 4-(hexyloxy)phenylcarbamate | Drug Info | [33] | |||
157 | 2-fluorophenyl 4-(octyloxy)phenylcarbamate | Drug Info | [33] | |||
158 | 2-fluorophenyl 4-(undecyloxy)phenylcarbamate | Drug Info | [33] | |||
159 | 2-fluorophenyl 4-butoxybenzylcarbamate | Drug Info | [33] | |||
160 | 2-fluorophenyl 4-butoxyphenylcarbamate | Drug Info | [33] | |||
161 | 2-fluorophenyl 4-phenoxyphenylcarbamate | Drug Info | [33] | |||
162 | 2-fluorophenylboronic acid | Drug Info | [34] | |||
163 | 2-methoxyphenylboronic acid | Drug Info | [34] | |||
164 | 3'-carbamoylbiphenyl-3-yl 6-phenylhexylcarbamate | Drug Info | [38] | |||
165 | 3,3-di(pent-4-enyl)azetidin-2-one | Drug Info | [19] | |||
166 | 3-(4,5-Dihydrooxazol-2-yl)phenyl propylcarbamate | Drug Info | [39] | |||
167 | 3-(benzo[d]oxazol-2-yl)phenyl propylcarbamate | Drug Info | [39] | |||
168 | 3-(biphenyl-4-yl)-1-(oxazol-2-yl)propan-1-one | Drug Info | [28] | |||
169 | 3-(decylsulfinyl)-1,1,1-trifluoropropan-2-one | Drug Info | [24] | |||
170 | 3-(decylsulfonyl)-1,1,1-trifluoropropan-2-one | Drug Info | [24] | |||
171 | 3-(decylthio)-1,1,1-trifluoropropan-2-one | Drug Info | [24] | |||
172 | 3-(dodecylsulfinyl)-1,1,1-trifluoropropan-2-one | Drug Info | [24] | |||
173 | 3-(dodecylsulfonyl)-1,1,1-trifluoropropan-2-one | Drug Info | [24] | |||
174 | 3-(ethoxycarbonyl)phenylboronic acid | Drug Info | [34] | |||
175 | 3-(trifluoromethyl)phenyl 4-butoxybenzylcarbamate | Drug Info | [33] | |||
176 | 3-(trifluoromethyl)phenylboronic acid | Drug Info | [34] | |||
177 | 3-chlorophenyl 4-butoxybenzylcarbamate | Drug Info | [33] | |||
178 | 3-cyanophenylboronic acid | Drug Info | [34] | |||
179 | 3-methoxyphenylboronic acid | Drug Info | [34] | |||
180 | 4-(1,2,3-thiadiazol-4-yl)phenyl butylcarbamate | Drug Info | [40] | |||
181 | 4-(1,2,3-thiadiazol-4-yl)phenyl hexylcarbamate | Drug Info | [40] | |||
182 | 4-(4,5-dihydrothiazol-2-yl)phenyl butylcarbamate | Drug Info | [40] | |||
183 | 4-(cyclohexylmethylcarbamoyloxy)benzoic acid | Drug Info | [38] | |||
184 | 4-(thiazol-2-yl)phenyl butylcarbamate | Drug Info | [41] | |||
185 | 4-(trifluoromethyl)phenylboronic acid | Drug Info | [34] | |||
186 | 4-cyanophenyl ethyl dodecylphosphonate | Drug Info | [42] | |||
187 | 4-cyanophenylboronic acid | Drug Info | [34] | |||
188 | 4-fluorophenyl 1-(4-butoxyphenyl)propylcarbamate | Drug Info | [33] | |||
189 | 4-fluorophenyl 4-butoxybenzylcarbamate | Drug Info | [33] | |||
190 | 4-fluorophenylboronic acid | Drug Info | [34] | |||
191 | 4-methoxyphenyl 1-(4-butoxyphenyl)propylcarbamate | Drug Info | [33] | |||
192 | 4-methoxyphenylboronic acid | Drug Info | [34] | |||
193 | 4-Nitrophenyl 4-Benzylpiperazine-1-carboxylate | Drug Info | [43] | |||
194 | 4-nitrophenylboronic acid | Drug Info | [34] | |||
195 | 4-nonylphenylboronic acid | Drug Info | [34] | |||
196 | 4-Phenylbutylcarbamic Acid Biphenyl-3-yl Ester | Drug Info | [37] | |||
197 | 6-fluoropyridin-3-ylboronic acid | Drug Info | [34] | |||
198 | 6-Phenylhexylcarbamic Acid Biphenyl-3-yl Ester | Drug Info | [37] | |||
199 | 7-Phenyl-1-(1,3,4-thiadiazol-2-yl)-heptan-1-one | Drug Info | [26] | |||
200 | 7-Phenyl-1-(2H-tetrazol-5-yl)-heptan-1-one | Drug Info | [26] | |||
201 | 7-phenyl-1-(4-phenyloxazol-2-yl)heptan-1-one | Drug Info | [27] | |||
202 | 7-phenyl-1-(5-phenyloxazol-2-yl)heptan-1-one | Drug Info | [26] | |||
203 | 7-Phenyl-1-(pyridazin-3-yl)-heptan-1-one | Drug Info | [26] | |||
204 | 7-Phenyl-1-(thiazol-2-yl)-heptan-1-one | Drug Info | [26] | |||
205 | 8-Phenyloctylcarbamic Acid Biphenyl-3-yl Ester | Drug Info | [37] | |||
206 | Adamant-1-ylcarbamic Acid Biphenyl-3-yl Ester | Drug Info | [37] | |||
207 | Allylcarbamic Acid Biphenyl-3-yl Ester | Drug Info | [37] | |||
208 | AM-404 | Drug Info | [44] | |||
209 | AR-C70484XX | Drug Info | [31] | |||
210 | ARACHIDONYL TRIFLUOROMETHYLKETONE | Drug Info | [31] | |||
211 | Benzaldehyde O-4-(decyloxy)phenylcarbamoyl oxime | Drug Info | [33] | |||
212 | Benzaldehyde O-4-(heptyloxy)phenylcarbamoyl oxime | Drug Info | [33] | |||
213 | Benzaldehyde O-4-(hexyloxy)phenylcarbamoyl oxime | Drug Info | [33] | |||
214 | Benzaldehyde O-4-(nonyloxy)phenylcarbamoyl oxime | Drug Info | [33] | |||
215 | Benzaldehyde O-4-(octyloxy)phenylcarbamoyl oxime | Drug Info | [33] | |||
216 | Benzaldehyde O-4-(pentyloxy)phenylcarbamoyl oxime | Drug Info | [33] | |||
217 | Benzaldehyde O-4-butoxyphenylcarbamoyl oxime | Drug Info | [33] | |||
218 | Benzaldehyde O-4-ethoxyphenylcarbamoyl oxime | Drug Info | [33] | |||
219 | Benzaldehyde O-4-methoxyphenylcarbamoyl oxime | Drug Info | [33] | |||
220 | Benzaldehyde O-4-propoxyphenylcarbamoyl oxime | Drug Info | [33] | |||
221 | Benzofuran-2-ylboronic acid | Drug Info | [34] | |||
222 | Benzo[b]thiophen-2-ylboronic acid | Drug Info | [34] | |||
223 | Benzylcarbamic Acid Biphenyl-3-yl Ester | Drug Info | [37] | |||
224 | Biphenyl-3-ylboronic acid | Drug Info | [34] | |||
225 | Biphenyl-3-ylcarbamic Acid Biphenyl-3-yl Ester | Drug Info | [37] | |||
226 | Biphenyl-3-ylcarbamic acid cyclohexyl ester | Drug Info | [25] | |||
227 | Biphenyl-4-ylboronic acid | Drug Info | [34] | |||
228 | BMS-1 | Drug Info | [45] | |||
229 | bromoenol lactone | Drug Info | [38] | |||
230 | Chlorphrifos oxon | Drug Info | [46] | |||
231 | Cyclobutylcarbamic Acid Biphenyl-3-yl Ester | Drug Info | [37] | |||
232 | Cyclohexyl biphenyl-4-ylcarbamate | Drug Info | [40] | |||
233 | Cyclohexylcarbamic acidbiphenyl-3-yl ester | Drug Info | [37] | |||
234 | Cyclohexylmethylcarbamic Acid Biphenyl-3-yl Ester | Drug Info | [37] | |||
235 | Cyclopentyl(5-(pyridin-2-yl)oxazol-2-yl)methanone | Drug Info | [36] | |||
236 | Cyclopentylcarbamic Acid Biphenyl-3-yl Ester | Drug Info | [37] | |||
237 | Dodecane-1-sulfonyl fluoride | Drug Info | [42] | |||
238 | Ethyl octylfluorophosphonate | Drug Info | [46] | |||
239 | Furan-2-ylmethylcarbamic Acid Biphenyl-3-yl Ester | Drug Info | [37] | |||
240 | HTS-00798 | Drug Info | [41] | |||
241 | Indan-2-ylcarbamic Acid Biphenyl-3-yl Ester | Drug Info | [37] | |||
242 | Isopropyl 4-nitrophenyl dodecylphosphonate | Drug Info | [42] | |||
243 | Isopropyl dodecylfluorophosphonate | Drug Info | [46] | |||
244 | Isopropylcarbamic Acid Biphenyl-3-yl Ester | Drug Info | [37] | |||
245 | JNJ-1661010 | Drug Info | [47] | |||
246 | LY-2183240 | Drug Info | [38] | |||
247 | LY-2318912 | Drug Info | [48] | |||
248 | Methoxy arachidonyl fluorophosphonate | Drug Info | [49] | |||
249 | Methyl 2-(7-phenylheptanoyl)oxazole-4-carboxylate | Drug Info | [27] | |||
250 | Methyl 2-(7-phenylheptanoyl)oxazole-5-carboxylate | Drug Info | [26] | |||
251 | Methyl icosylphosphonofluoridate | Drug Info | [42] | |||
252 | Methylcarbamic Acid Biphenyl-3-yl Ester | Drug Info | [37] | |||
253 | N-(2-hydroxyethyl)linoleoylamide | Drug Info | [50] | |||
254 | N-(2-iodethyl)arachidonylamide | Drug Info | [50] | |||
255 | N-(2-iodoethyl)linoleoylamide | Drug Info | [50] | |||
256 | N-(4-hydroxybenzyl)icosa-5,8,11,14-tetraenamide | Drug Info | [44] | |||
257 | N-arachidonylmaleimide | Drug Info | [25] | |||
258 | N-Butylcarbamic Acid Biphenyl-3-yl Ester | Drug Info | [37] | |||
259 | N-Hexylcarbamic Acid Biphenyl-3-yl Ester | Drug Info | [37] | |||
260 | N-Octylcarbamic Acid Biphenyl-3-yl Ester | Drug Info | [37] | |||
261 | Naphthalen-2-yl cyclohexylcarbamate | Drug Info | [38] | |||
262 | NICARBAZIN | Drug Info | [51] | |||
263 | Nicotinaldehyde O-4-butoxyphenylcarbamoyl oxime | Drug Info | [33] | |||
264 | Nicotinaldehyde O-4-ethoxyphenylcarbamoyl oxime | Drug Info | [33] | |||
265 | Nicotinaldehyde O-4-propoxyphenylcarbamoyl oxime | Drug Info | [33] | |||
266 | Octane-1-sulfonyl fluoride | Drug Info | [42] | |||
267 | OL-135 | Drug Info | [52] | |||
268 | OL-92 | Drug Info | [45] | |||
269 | Org-231295 | Drug Info | [16], [31] | |||
270 | PARAOXON | Drug Info | [46] | |||
271 | PF3845 | Drug Info | [53] | |||
272 | PF750 | Drug Info | [54] | |||
273 | Phenethylboronic acid | Drug Info | [34] | |||
274 | Phenethylcarbamic Acid Biphenyl-3-yl Ester | Drug Info | [37] | |||
275 | PHENMEDIPHAM | Drug Info | [51] | |||
276 | Phenyl 1-(4-butoxyphenyl)propylcarbamate | Drug Info | [33] | |||
277 | Phenyl 4-(decyloxy)phenylcarbamate | Drug Info | [33] | |||
278 | Phenyl 4-(dodecyloxy)phenylcarbamate | Drug Info | [33] | |||
279 | Phenyl 4-(heptyloxy)phenylcarbamate | Drug Info | [33] | |||
280 | Phenyl 4-(hexyloxy)phenylcarbamate | Drug Info | [33] | |||
281 | Phenyl 4-(octyloxy)phenylcarbamate | Drug Info | [33] | |||
282 | Phenyl 4-(undecyloxy)phenylcarbamate | Drug Info | [33] | |||
283 | Phenyl Boronic acid | Drug Info | [34] | |||
284 | Phenyl-1,4-bismaleimide | Drug Info | [25] | |||
285 | Phenylcarbamic Acid Biphenyl-3-yl Ester | Drug Info | [37] | |||
286 | Propan-2-one O-3-butoxyphenylcarbamoyl oxime | Drug Info | [33] | |||
287 | Propan-2-one O-4-(decyloxy)phenylcarbamoyl oxime | Drug Info | [33] | |||
288 | Propan-2-one O-4-(heptyloxy)phenylcarbamoyl oxime | Drug Info | [33] | |||
289 | Propan-2-one O-4-(hexyloxy)phenylcarbamoyl oxime | Drug Info | [33] | |||
290 | Propan-2-one O-4-(nonyloxy)phenylcarbamoyl oxime | Drug Info | [33] | |||
291 | Propan-2-one O-4-(octyloxy)phenylcarbamoyl oxime | Drug Info | [33] | |||
292 | Propan-2-one O-4-(pentyloxy)phenylcarbamoyl oxime | Drug Info | [33] | |||
293 | Propan-2-one O-4-butoxybenzylcarbamoyl oxime | Drug Info | [33] | |||
294 | Propan-2-one O-4-butoxyphenylcarbamoyl oxime | Drug Info | [33] | |||
295 | Propan-2-one O-4-ethoxyphenylcarbamoyl oxime | Drug Info | [33] | |||
296 | Propan-2-one O-4-propoxyphenylcarbamoyl oxime | Drug Info | [33] | |||
297 | Pyridin-3-yl 4-butoxybenzylcarbamate | Drug Info | [33] | |||
298 | VER-156084 | Drug Info | [55] | |||
Modulator | [+] 1 Modulator drugs | + | ||||
1 | IW-6118 | Drug Info | [12] |
Drug Property Profile of Target | Top | |
---|---|---|
(1) Molecular Weight (mw) based Drug Clustering | (2) Octanol/Water Partition Coefficient (xlogp) based Drug Clustering | |
|
||
(3) Hydrogen Bond Donor Count (hbonddonor) based Drug Clustering | (4) Hydrogen Bond Acceptor Count (hbondacc) based Drug Clustering | |
|
||
(5) Rotatable Bond Count (rotbonds) based Drug Clustering | (6) Topological Polar Surface Area (polararea) based Drug Clustering | |
|
||
"RO5" indicates the cutoff set by lipinski's rule of five; "D123AB" colored in GREEN denotes the no violation of any cutoff in lipinski's rule of five; "D123AB" colored in PURPLE refers to the violation of only one cutoff in lipinski's rule of five; "D123AB" colored in BLACK represents the violation of more than one cutoffs in lipinski's rule of five |
Co-Targets | Top | |||||
---|---|---|---|---|---|---|
Co-Targets |
Target Profiles in Patients | Top | |||||
---|---|---|---|---|---|---|
Target Expression Profile (TEP) |
Target Affiliated Biological Pathways | Top | |||||
---|---|---|---|---|---|---|
BioCyc | [+] 1 BioCyc Pathways | + | ||||
1 | Anandamide degradation | |||||
KEGG Pathway | [+] 1 KEGG Pathways | + | ||||
1 | Retrograde endocannabinoid signaling | |||||
Panther Pathway | [+] 1 Panther Pathways | + | ||||
1 | Anandamide degradation |
Target-Related Models and Studies | Top | |||||
---|---|---|---|---|---|---|
Target Validation |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase. Br J Pharmacol. 2003 Jul;139(5):1005-13. | |||||
REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5464). | |||||
REF 3 | Propofol in anesthesia. Mechanism of action, structure-activity relationships, and drug delivery. Curr Med Chem. 2000 Feb;7(2):249-71. | |||||
REF 4 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2579). | |||||
REF 5 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 011679. | |||||
REF 6 | ClinicalTrials.gov (NCT01107236) Study to Evaluate Efficacy and Safety of IW-6118 in Patients Undergoing Third Molar Extraction. U.S. National Institutes of Health. | |||||
REF 7 | ClinicalTrials.gov (NCT02498392) An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress. | |||||
REF 8 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6694). | |||||
REF 9 | ClinicalTrials.gov (NCT00822744) An Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly Patients. U.S. National Institutes of Health. | |||||
REF 10 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800029245) | |||||
REF 11 | Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol. 2006 Feb;6(1):7-17. | |||||
REF 12 | The Discovery and Development of Inhibitors of Fatty Acid Amide Hydrolase (FAAH). Bioorg Med Chem Lett. 2011 August 15; 21(16): 4674-4685. | |||||
REF 13 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||||
REF 14 | Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor. ACS Med Chem Lett. 2011 Feb 10;2(2):91-96. | |||||
REF 15 | Pharma & Vaccines. Product Development Pipeline. April 29 2009. | |||||
REF 16 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1400). | |||||
REF 17 | Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).Expert Opin Ther Pat. 2015;25(11):1247-66. | |||||
REF 18 | A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017).Expert Opin Ther Pat. 2017 Dec;27(12):1341-1351. | |||||
REF 19 | 3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors. Bioorg Med Chem Lett. 2008 Jul 15;18(14):4163-7. | |||||
REF 20 | Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis--comparison with effects upon fatty acid amide hydrolase. J Med Chem. 2007 Oct 4;50(20):5012-23. | |||||
REF 21 | Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as a... J Med Chem. 2005 Mar 24;48(6):1849-56. | |||||
REF 22 | Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality. Bioorg Med Chem. 2008 Feb 15;16(4):1562-95. | |||||
REF 23 | alpha-Keto heterocycle inhibitors of fatty acid amide hydrolase: carbonyl group modification and alpha-substitution. Bioorg Med Chem Lett. 2001 Jun 18;11(12):1517-20. | |||||
REF 24 | Influence of sulfur oxidation state and steric bulk upon trifluoromethyl ketone (TFK) binding kinetics to carboxylesterases and fatty acid amide hy... Bioorg Med Chem. 2008 Feb 15;16(4):2114-30. | |||||
REF 25 | Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors. J Med Chem. 2009 Dec 10;52(23):7410-20. | |||||
REF 26 | Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase. J Med Chem. 2008 Aug 14;51(15):4392-403. | |||||
REF 27 | Exploration of a fundamental substituent effect of alpha-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fatty acid amide hyd... Bioorg Med Chem Lett. 2008 Nov 15;18(22):5842-6. | |||||
REF 28 | Optimization of alpha-ketooxazole inhibitors of fatty acid amide hydrolase. J Med Chem. 2008 Feb 28;51(4):937-47. | |||||
REF 29 | Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH). Bioorg Med Chem Lett. 2008 Mar 15;18(6):2109-13. | |||||
REF 30 | The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. | |||||
REF 31 | 1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A(2)alpha and fatty acid amide hydrolase. Bioorg Med Chem. 2010 Jan 15;18(2):945-52. | |||||
REF 32 | The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. J Med Chem. 2005 Aug 11;48(16):5059-87. | |||||
REF 33 | Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7. | |||||
REF 34 | Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase. J Med Chem. 2008 Nov 27;51(22):7057-60. | |||||
REF 35 | Conformationally constrained analogues of 2-arachidonoylglycerol. Bioorg Med Chem Lett. 2007 Nov 1;17(21):5959-63. | |||||
REF 36 | Structure-activity relationships of alpha-ketooxazole inhibitors of fatty acid amide hydrolase. J Med Chem. 2007 Jul 12;50(14):3359-68. | |||||
REF 37 | Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl a... J Med Chem. 2008 Jun 26;51(12):3487-98. | |||||
REF 38 | Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors. J Med Chem. 2008 Dec 11;51(23):7327-43. | |||||
REF 39 | Chiral 3-(4,5-dihydrooxazol-2-yl)phenyl alkylcarbamates as novel FAAH inhibitors: Insight into FAAH enantioselectivity by molecular docking and int... Eur J Med Chem. 2009 Oct;44(10):4179-91. | |||||
REF 40 | The synthesis and biological evaluation of para-substituted phenolic N-alkyl carbamates as endocannabinoid hydrolyzing enzyme inhibitors. Eur J Med Chem. 2009 Jul;44(7):2994-3008. | |||||
REF 41 | Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system. J Med Chem. 2006 Jul 27;49(15):4650-6. | |||||
REF 42 | Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels. Bioorg Med Chem Lett. 2008 Nov 15;18(22):5875-8. | |||||
REF 43 | Characterization of tunable piperidine and piperazine carbamates as inhibitors of endocannabinoid hydrolases. J Med Chem. 2010 Feb 25;53(4):1830-42. | |||||
REF 44 | New analgesics synthetically derived from the paracetamol metabolite N-(4-hydroxyphenyl)-(5Z,8Z,11Z,14Z)-icosatetra-5,8,11,14-enamide. J Med Chem. 2008 Dec 25;51(24):7800-5. | |||||
REF 45 | Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors. J Med Chem. 2009 Jan 8;52(1):170-80. | |||||
REF 46 | Activation of the endocannabinoid system by organophosphorus nerve agents. Nat Chem Biol. 2008 Jun;4(6):373-8. | |||||
REF 47 | Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase. Bioorg Med Chem Lett. 2008 Sep 1;18(17):4838-43. | |||||
REF 48 | Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation. Eur J Med Chem. 2008 Jan;43(1):62-72. | |||||
REF 49 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||||
REF 50 | Radiosynthesis, in vitro and in vivo evaluation of 123I-labeled anandamide analogues for mapping brain FAAH. Bioorg Med Chem. 2009 Jan 1;17(1):49-56. | |||||
REF 51 | Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inh... Bioorg Med Chem Lett. 2009 Dec 1;19(23):6793-6. | |||||
REF 52 | X-ray crystallographic analysis of alpha-ketoheterocycle inhibitors bound to a humanized variant of fatty acid amide hydrolase. J Med Chem. 2010 Jan 14;53(1):230-40. | |||||
REF 53 | Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain. Chem Biol. 2009 Apr 24;16(4):411-20. | |||||
REF 54 | Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity. Biochemistry. 2007 Nov 13;46(45):13019-30. | |||||
REF 55 | Fatty acid amide hydrolase inhibitors. Surprising selectivity of chiral azetidine ureas. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4241-4. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.